The first in-human Phase I study of a BET inhibitor for the treatment of NHL
Ibrutinib vs temsirolimus in relapsed/refractory mantle cell lymphoma
Highlights of ASH in CLL
John Gribben et al.
The progress in treating Hodgkin lymphoma
The EPOCH-R clinical trial in Burkitt lymphoma